Getting under the Skin: The Immunopathogenesis of Streptococcus pyogenes Deep Tissue Infections

被引:107
作者
Johansson, Linda [1 ]
Thulin, Pontus [1 ,2 ]
Low, Donald E. [3 ,4 ]
Norrby-Teglund, Anna [1 ]
机构
[1] Karolinska Inst, Ctr Infect Med, Karolinska Univ Hosp Huddinge, S-141866 Stockholm, Sweden
[2] Univ Hosp Orebro, Dept Urol, Orebro, Sweden
[3] Mt Sinai Hosp, Dept Microbiol, Toronto, ON M5G 1X5, Canada
[4] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada
基金
瑞典研究理事会;
关键词
GROUP-A STREPTOCOCCI; TOXIC-SHOCK-SYNDROME; POLYSPECIFIC IMMUNOGLOBULIN; SUPERANTIGEN INVOLVEMENT; ANTIMICROBIAL PEPTIDES; NECROTIZING FASCIITIS; M-PROTEIN; T-CELLS; IN-VIVO; VIRULENCE;
D O I
10.1086/653116
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Streptococcus pyogenes can cause a variety of diseases in immunocompetent individuals, from pharyngotonsillitis to life-threatening invasive diseases, such as streptococcal toxic shock syndrome, and rapidly progressing deep-tissue infections, such as necrotizing fasciitis. Necrotizing fasciitis is often seen in combination with streptococcal toxic shock syndrome, which further increases morbidity and mortality. We review here the host-pathogen interactions in the tissue milieu and discuss the use of intravenous immunoglobulin as potential adjunctive therapy in these life-threatening infections.
引用
收藏
页码:58 / 65
页数:8
相关论文
共 72 条
  • [1] STREPTOCOCCAL MYOSITIS
    ADAMS, EM
    GUDMUNDSSON, S
    YOCUM, DE
    HASELBY, RC
    CRAIG, WA
    SUNDSTROM, WR
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (06) : 1020 - 1023
  • [2] Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB
    Aziz, RK
    Pabst, MJ
    Jeng, A
    Kansal, R
    Low, DE
    Nizet, V
    Kotb, M
    [J]. MOLECULAR MICROBIOLOGY, 2004, 51 (01) : 123 - 134
  • [3] Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases
    Ballow, M
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (02) : 151 - 157
  • [4] Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): Potential impact on the clinical efficacy of IVIG therapy for severe invasive group a streptococcal infections
    Basma, H
    Norrby-Teglund, A
    McGeer, A
    Low, DE
    El-Ahmedy, O
    Dale, JB
    Schwartz, B
    Kotb, M
    [J]. INFECTION AND IMMUNITY, 1998, 66 (05) : 2279 - 2283
  • [5] Basma H, 1999, INFECT IMMUN, V67, P1871
  • [6] Functions of antimicrobial peptides in host defense and immunity
    Beisswenger, C
    Bals, R
    [J]. CURRENT PROTEIN & PEPTIDE SCIENCE, 2005, 6 (03) : 255 - 264
  • [7] Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus
    Beres, SB
    Richter, EW
    Nagiec, MJ
    Sumby, P
    Porcella, SF
    Deleo, FR
    Musser, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (18) : 7059 - 7064
  • [8] Genetic correlates of throat and skin isolates of group A streptococci
    Bessen, DE
    Sotir, CM
    Readdy, TL
    Hollingshead, SK
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (04) : 896 - 900
  • [9] Group A streptococcal myonecrosis:: Increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes
    Bryant, AE
    Bayer, CR
    Huntington, JD
    Stevens, DL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (12) : 1685 - 1692
  • [10] Vascular dysfunction and ischemic destruction of tissue in streptococcus pyogenes infection: The role of streptolysin O - Induced platelet/neutrophil complexes
    Bryant, AE
    Bayer, CR
    Chen, RYZ
    Guth, PH
    Wallace, RJ
    Stevens, DL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06) : 1014 - 1022